Head-to-Head

Lifecore Biomedical, Inc. Common Stock vs. Eli Lilly & Co.

LFCR

Lifecore Biomedical, Inc. Common Stock

$6.52 +55.24%

VS LLY

Eli Lilly & Co.

$1184.78 +0.11%

Lifecore Biomedical, Inc. Common Stock (LFCR) comes out ahead, leading on 2 of 3 compared factors.

Size & Scale

LFCRLLY
Market Cap $158.98 million $1.06 trillion
Revenue (TTM) — $79.67 billion
Net Income (TTM) — $26.71 billion

LLY leads on 1 of 1 size & scale factors.

Valuation

LFCRLLY
P/E Ratio — 39.77
Price / Book -4.66 31.17
Price / Sales — 13.26

LFCR leads on 1 of 1 valuation factors.

Profitability

LFCRLLY
Net Margin — 33.53%
Return on Equity — 78.84%

LFCR and LLY split the profitability factors evenly.

Dividend

LFCRLLY
Dividend Yield — 0.58%
Payout Ratio — 23.23

LFCR and LLY split the dividend factors evenly.

Risk & Sentiment

LFCRLLY
Short Interest 0.90% 1.29%

LFCR leads on 1 of 1 risk & sentiment factors.

Dig deeper: LFCR overview, LFCR financials, LLY overview, LLY financials.

Comparisons use delayed, cached fundamental data and cover only the factors shown. For informational purposes only — not investment advice.